Recurrent hepatitis B virus (HBV) infection in immune globulin-treated liver transplant patients: role of S mutants
2000-01-01 Santantonio, TERESA ANTONIA; Marzano, A.; Sinisi, E.; Mazzola, M.; Guastadisengni, A.; Rendina, M.; Mangia, A.; Bellati, G.; Gaeta, G. b.; Francavilla, A.; Pastore, G.
Long term lamivudine treatment in anti-HBe positive chronic hepatitis B: an interim analysis
2000-01-01 Santantonio, TERESA ANTONIA; Mazzola, M.; Sinisi, E.; Insalata, M.; Milella, M.; Guastadisegni, A.; Pastore, G.
The HBV immune escape mutant Gly145Arg shows a defect for secretion of virions
2000-01-01 Sterneck, M.; Kalinina, T.; Santantonio, TERESA ANTONIA; Riu, A.; Fischer, L.; Will, H.
Detection of HCV-specific CD8+ T cells in acute hepatitis C which are impaired in cytolytic function and production of cytokines
2000-01-01 Gruener, N. h.; Lechner, F.; Jung, M. c.; Diepolder, H.; Gerlach, T. j.; Zachoval, R. z.; Schraut, W.; Schirren, A. c.; Santantonio, TERESA ANTONIA; Klenerman, P.; Pape, G. r.
Twelve months of lamivudine/Interferon combination therapy prevents the appearance of YMDD mutants in patients with anti-HBe positive chronic hepatitis B: a controlled pilot study
2001-01-01 Santantonio, TERESA ANTONIA; Niro, G.; Insalata, M.; Sinisi, E.; Facciorusso, D.; Gravinese, E.; Andriulli, A.; Pastore, G.
Clinical and histological outcome of extended lamivudine in patients with HBeAg negative chronic hepatitis B
2001-01-01 Esteban, R. d. g.; Tassopoulos, N. c.; Rizzetto, M.; Santantonio, TERESA ANTONIA; Heathcote, J.; Woessner, M.; Taak, N. k.
Lamivudine/interferon combination therapy for 12 months prevents the appearance of YMDD mutants in anti-HBe positive chronic hepatitis B patients: a controlled pilot study
2001-01-01 Santantonio, TERESA ANTONIA; Niro, G.; Sinisi, E.; Insalata, M.; Facciorusso, D.; Gravinese, E.; Andriulli, A.; Pastore, G.
Long-term lamivudine treatment in anti-HBe positive chronic hepatitis B: an interim analysis
2001-01-01 Santantonio, TERESA ANTONIA; Sinisi, E.; Mazzola, M.; Insalata, M.; Guastadisegni, A.; Pastore, G.
Lamivudine-resistant HBV mutants in patients with anti-Hbe positive chronic hepatitis B treated with long-term lamivudine monotherapy
2002-01-01 Santantonio, TERESA ANTONIA; Sinisi, E.; Insalata, M.; Palumbo, E.; Guastadisegni, A.; Pastore, G.
Interferon alone versus interferon plus ribavirin in the treatment of patients with acute hepatitis C
2002-01-01 Santantonio, TERESA ANTONIA; Sinisi, E.; Guastadisegni, A.; Palumbo, E.; Pastore, G.
Long term lamivudine in patients with anti-Hbe/HBV-DNA positive liver disease
2002-01-01 Di Marco, V.; Lampertico, P.; Marzano, A.; Andreone, P.; Santantonio, TERESA ANTONIA; Almasio, P.; Rizzetto, M.; Craxì, A.
Human immune deficiency virus(HIV) co-infection impairs responsiveness to interferon (IFN) and ribavirin (RBV) combination in patients with chronic hepatitis C: Preliminary results of a comparative study
2002-01-01 Puoti, M.; Zanini, B.; Quinzan, P.; Santantonio, TERESA ANTONIA; Cavaliere, R.; Castelli, F.; Zaltron, S.; Roldan, E. q.; Suter, F.; Pastore, G.; Carosi, G.
Preliminary results of a randomized multicenter controlled trial comparing interferon (IFN) thrice weekly in combination with ribavirin (RBV) with interferon daily in combination with ribavirin and amantadine (AMA) in the treatment of chronic hepatitis C in human immune deficiency virus (HIV) co-infected patients
2002-01-01 Puoti, M.; Zanini, B.; Quinzan, P.; Santantonio, TERESA ANTONIA; Cavaliere, R.; Roldan, E. q.; Castelli, F.; Suter, F.; Pastore, G.; Carosi, G.
High interferon (IFN) daily doses in combination with ribavirin (RBV) are cost effective in the treatment of hepatitis C in HIV coinfected subjects without sustained response to interferon monotherapy
2002-01-01 Puoti, M.; Zanini, B.; Quinzan, P.; Santantonio, TERESA ANTONIA; Scalise, G.; Ghinelli, F.; Chiodo, R.; Pastore, G.; Castelli, F.; Carosi, G.
Clinical events during long term lamivudine treatment in anti-HBe/HBV DNA positive chronic liver diseases
2003-01-01 Di Marco, V.; Marzano, A.; Lampertico, P.; Andreone, P.; Santantonio, TERESA ANTONIA; Almasio, P. l.; Rizzetto, M.; Craxì, A.
Genotypic analysis of YMDD locus of HBV in patients responding to lamivudine monotherapy.
2003-01-01 Lampertico, P.; Seletti, C.; Vigano, M.; Marzano, A.; Andreone, P.; Santantonio, TERESA ANTONIA; Di Marco, V.; Iavarone, M.; Lunghi, G.; Del Ninno, E.; Colombo, M.
The course of anti-HBe/HBV-DNA positive chronic liver disease during long term lamivudine treatment
2003-01-01 Di Marco, V.; Marzano, A.; Lampertico, P.; Andreone, P.; Santantonio, TERESA ANTONIA; Almasio, P. l.; Rizzetto, M.; Craxìa,
Successful treatment of acute hepatitis C with alpha-2b Peg-Interferon monotherapy: an interim analysis
2003-01-01 Santantonio, TERESA ANTONIA; Sinisi, E.; Signorile, F.; Guastadisegni, A.; Casalino, C.; Mazzola, M.; Francavilla, R.; Pastore, G.
Efficacy of peg-interferon alpha-2b (pegintron) monotherapy in acute hepatitis C: a preliminary analysis
2004-01-01 Santantonio, TERESA ANTONIA; Sinisi, E.; Signorile, F.; Guastadisegni, A.; Casalino, C.; Mazzola, M.; Francavilla, R.; Pastore, G.
.Dynamics of HBV-DNA and infected hepatocytes described by a new bio-mathematical model in chronic hepatitis B patients treated with lamivudine and in patients with YMDD mutants treated with adefovir
2004-01-01 Bizzarri, R.; Colombatto, P.; Civitano, L.; Flichman, D.; Ciccorossi, P.; Sacco, R.; Olivieri, F.; Coco, B.; Maina, A.; Bonino, F.; Santantonio, TERESA ANTONIA; Brunetto, M.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Recurrent hepatitis B virus (HBV) infection in immune globulin-treated liver transplant patients: role of S mutants | 1-gen-2000 | Santantonio, TERESA ANTONIA; Marzano, A.; Sinisi, E.; Mazzola, M.; Guastadisengni, A.; Rendina, M.; Mangia, A.; Bellati, G.; Gaeta, G. b.; Francavilla, A.; Pastore, G. | |
Long term lamivudine treatment in anti-HBe positive chronic hepatitis B: an interim analysis | 1-gen-2000 | Santantonio, TERESA ANTONIA; Mazzola, M.; Sinisi, E.; Insalata, M.; Milella, M.; Guastadisegni, A.; Pastore, G. | |
The HBV immune escape mutant Gly145Arg shows a defect for secretion of virions | 1-gen-2000 | Sterneck, M.; Kalinina, T.; Santantonio, TERESA ANTONIA; Riu, A.; Fischer, L.; Will, H. | |
Detection of HCV-specific CD8+ T cells in acute hepatitis C which are impaired in cytolytic function and production of cytokines | 1-gen-2000 | Gruener, N. h.; Lechner, F.; Jung, M. c.; Diepolder, H.; Gerlach, T. j.; Zachoval, R. z.; Schraut, W.; Schirren, A. c.; Santantonio, TERESA ANTONIA; Klenerman, P.; Pape, G. r. | |
Twelve months of lamivudine/Interferon combination therapy prevents the appearance of YMDD mutants in patients with anti-HBe positive chronic hepatitis B: a controlled pilot study | 1-gen-2001 | Santantonio, TERESA ANTONIA; Niro, G.; Insalata, M.; Sinisi, E.; Facciorusso, D.; Gravinese, E.; Andriulli, A.; Pastore, G. | |
Clinical and histological outcome of extended lamivudine in patients with HBeAg negative chronic hepatitis B | 1-gen-2001 | Esteban, R. d. g.; Tassopoulos, N. c.; Rizzetto, M.; Santantonio, TERESA ANTONIA; Heathcote, J.; Woessner, M.; Taak, N. k. | |
Lamivudine/interferon combination therapy for 12 months prevents the appearance of YMDD mutants in anti-HBe positive chronic hepatitis B patients: a controlled pilot study | 1-gen-2001 | Santantonio, TERESA ANTONIA; Niro, G.; Sinisi, E.; Insalata, M.; Facciorusso, D.; Gravinese, E.; Andriulli, A.; Pastore, G. | |
Long-term lamivudine treatment in anti-HBe positive chronic hepatitis B: an interim analysis | 1-gen-2001 | Santantonio, TERESA ANTONIA; Sinisi, E.; Mazzola, M.; Insalata, M.; Guastadisegni, A.; Pastore, G. | |
Lamivudine-resistant HBV mutants in patients with anti-Hbe positive chronic hepatitis B treated with long-term lamivudine monotherapy | 1-gen-2002 | Santantonio, TERESA ANTONIA; Sinisi, E.; Insalata, M.; Palumbo, E.; Guastadisegni, A.; Pastore, G. | |
Interferon alone versus interferon plus ribavirin in the treatment of patients with acute hepatitis C | 1-gen-2002 | Santantonio, TERESA ANTONIA; Sinisi, E.; Guastadisegni, A.; Palumbo, E.; Pastore, G. | |
Long term lamivudine in patients with anti-Hbe/HBV-DNA positive liver disease | 1-gen-2002 | Di Marco, V.; Lampertico, P.; Marzano, A.; Andreone, P.; Santantonio, TERESA ANTONIA; Almasio, P.; Rizzetto, M.; Craxì, A. | |
Human immune deficiency virus(HIV) co-infection impairs responsiveness to interferon (IFN) and ribavirin (RBV) combination in patients with chronic hepatitis C: Preliminary results of a comparative study | 1-gen-2002 | Puoti, M.; Zanini, B.; Quinzan, P.; Santantonio, TERESA ANTONIA; Cavaliere, R.; Castelli, F.; Zaltron, S.; Roldan, E. q.; Suter, F.; Pastore, G.; Carosi, G. | |
Preliminary results of a randomized multicenter controlled trial comparing interferon (IFN) thrice weekly in combination with ribavirin (RBV) with interferon daily in combination with ribavirin and amantadine (AMA) in the treatment of chronic hepatitis C in human immune deficiency virus (HIV) co-infected patients | 1-gen-2002 | Puoti, M.; Zanini, B.; Quinzan, P.; Santantonio, TERESA ANTONIA; Cavaliere, R.; Roldan, E. q.; Castelli, F.; Suter, F.; Pastore, G.; Carosi, G. | |
High interferon (IFN) daily doses in combination with ribavirin (RBV) are cost effective in the treatment of hepatitis C in HIV coinfected subjects without sustained response to interferon monotherapy | 1-gen-2002 | Puoti, M.; Zanini, B.; Quinzan, P.; Santantonio, TERESA ANTONIA; Scalise, G.; Ghinelli, F.; Chiodo, R.; Pastore, G.; Castelli, F.; Carosi, G. | |
Clinical events during long term lamivudine treatment in anti-HBe/HBV DNA positive chronic liver diseases | 1-gen-2003 | Di Marco, V.; Marzano, A.; Lampertico, P.; Andreone, P.; Santantonio, TERESA ANTONIA; Almasio, P. l.; Rizzetto, M.; Craxì, A. | |
Genotypic analysis of YMDD locus of HBV in patients responding to lamivudine monotherapy. | 1-gen-2003 | Lampertico, P.; Seletti, C.; Vigano, M.; Marzano, A.; Andreone, P.; Santantonio, TERESA ANTONIA; Di Marco, V.; Iavarone, M.; Lunghi, G.; Del Ninno, E.; Colombo, M. | |
The course of anti-HBe/HBV-DNA positive chronic liver disease during long term lamivudine treatment | 1-gen-2003 | Di Marco, V.; Marzano, A.; Lampertico, P.; Andreone, P.; Santantonio, TERESA ANTONIA; Almasio, P. l.; Rizzetto, M.; Craxìa, | |
Successful treatment of acute hepatitis C with alpha-2b Peg-Interferon monotherapy: an interim analysis | 1-gen-2003 | Santantonio, TERESA ANTONIA; Sinisi, E.; Signorile, F.; Guastadisegni, A.; Casalino, C.; Mazzola, M.; Francavilla, R.; Pastore, G. | |
Efficacy of peg-interferon alpha-2b (pegintron) monotherapy in acute hepatitis C: a preliminary analysis | 1-gen-2004 | Santantonio, TERESA ANTONIA; Sinisi, E.; Signorile, F.; Guastadisegni, A.; Casalino, C.; Mazzola, M.; Francavilla, R.; Pastore, G. | |
.Dynamics of HBV-DNA and infected hepatocytes described by a new bio-mathematical model in chronic hepatitis B patients treated with lamivudine and in patients with YMDD mutants treated with adefovir | 1-gen-2004 | Bizzarri, R.; Colombatto, P.; Civitano, L.; Flichman, D.; Ciccorossi, P.; Sacco, R.; Olivieri, F.; Coco, B.; Maina, A.; Bonino, F.; Santantonio, TERESA ANTONIA; Brunetto, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista1289
Data di pubblicazione
- 2020 - 202417
- 2010 - 2019573
- 2000 - 2009486
- 1990 - 1999174
- 1980 - 198935
- 1974 - 19794
Editore
- Edizioni Ets:Piazza Carrara 16-19...3
- New York ; : Taylor & Francis, 20...2
- Editrice Kurtis Srl:via Luigi Zoj...1
Rivista
- DIGESTIVE AND LIVER DISEASE78
- THE JOURNAL OF THE AMERICAN ASSOC...72
- EUROPEAN RESPIRATORY JOURNAL71
- JOURNAL OF HEPATOLOGY69
- GIORNALE ITALIANO DI PSICOPATOLOGIA54
- HEPATOLOGY50
- ARCHIVES OF DISEASE IN CHILDHOOD26
- JOURNAL OF PEDIATRIC GASTROENTERO...23
- DIGESTIVE AND LIVER DISEASE. SUPP...20
- EUROPEAN PSYCHIATRY20
Keyword
- children15
- obesity5
- Physical education4
- grapevine3
- kidney3
- Metabolic syndrome3
- physical activity3
- physical education3
- primary school3
- self-efficacy3
Lingua
- eng708
- ita146
- fre1
Accesso al fulltext
- no fulltext1289